Skip to main content

Continuous Circulation of Hepatitis E and A Viruses During COVID-19 Pandemic Lockdowns in Munich, Germany-Experience from Three Years of Wastewater Surveillance.

Microorganisms

Authors: Jasmin Javanmardi, Mathias Schemmerer, Karina Wallrafen-Sam, Jessica Neusser, Raquel Rubio-Acero, Michael Hoelscher, Thomas Kletke, Bernhard Boehm, Michael Schneider, Elisabeth Waldeck, Martin Hoch, Merle M Böhmer, Christof Geldmacher, Jan Hasenauer, Jürgen J Wenzel, Andreas Wieser

The COVID-19 pandemic has increased interest in wastewater-based epidemiology (WBE) as a reliable and cost-effective framework for monitoring the spread of microbes. However, WBE frameworks have rarely been applied to the study of fecal-oral transmissible diseases, except for poliomyelitis. Here, we investigated the presence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in wastewater in Munich. We collected wastewater samples between July 2020 and November 2023. A total of 186 samples were processed using centrifugation and analyzed for HAV- and HEV-RNA using RT-qPCR. As a reference, we used notification data from clinically or laboratory-diagnosed hepatitis A and E cases. Lockdown stringency levels were derived from official documentation. Our results show that 87.6% of wastewater samples were positive for HEV at concentrations of 9.0 × 10 to 2.5 × 10 copies/L, while HAV was only detectable in 7.5% of the samples at viral loads of 4.6 × 10 to 2.4 × 10 copies/L. We also detected differences in HEV concentrations but not in case numbers when comparing lockdown and no-lockdown periods. This study covers all but the first lockdowns in Bavaria. We present a unique real-world dataset evaluating the impact of lockdown interventions on hepatitis A and E case numbers, as well as on the concentrations of HAV and HEV in wastewater. Person-to-person spread and eating out appear to have contributed to the transmission of HEV. In addition, the consistently high HEV concentrations in sewage support the findings of serological studies, indicating a substantial burden of undetected subclinical infections.

PMID: 41156838

Participating cluster members